1 completed, 1 terminated, 1 unknown. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Mucoepidermoid Carcinoma: new trials by email Literature Review of Mucoepidermoid Carcinoma trials Research Report on Mucoepidermoid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) P-PSMA-101 CAR-T cells, Rimiducid - Prostatic Neoplasms, Castration-Resistant, Neoplasms by Histologic Type | Phase 1 | Terminated | Poseida Therapeutics, Inc. | 40 | 2020-02-28 | 2025-02-17 |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene A166 - HER2-positive Breast Cancer, HER2 Gene Mutation | Phase 1 / Phase 2 | Completed | Klus Pharma Inc. | 49 | 2018-07-16 | 2023-08-03 |
| Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy Proton radiation therapy, Intensity-modulated radiotherapy - Adenoid Cystic Carcinoma, Squamous Cell Carcinoma | Not applicable | Unknown | Massachusetts General Hospital | 45 | 2011-07-12 | 2023-09-21 |
Carcinoma, Mucoepidermoid (3) · Carcinoma, Adenoid Cystic (2) · Prostatic Neoplasms (2) · Salivary Gland Neoplasms (2) · Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Acinar Cell (1) · Carcinoma, Renal Cell (1) · Carcinoma, Squamous Cell (1) · Cholangiocarcinoma (1) · Colonic Neoplasms (1) · Esthesioneuroblastoma, Olfactory (1) · Fistula (1) · Genital Neoplasms, Male (1) · Head and Neck Neoplasms (1)
Adenocarcinoma (3) · Carcinoma (3) · Neoplasms, Cystic, Mucinous, and Serous (3) · Neoplasms, Glandular and Epithelial (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Male Urogenital Diseases (2) · Mouth Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Pathological Conditions, Signs and Symptoms (2) · Salivary Gland Diseases (2)
Protons (1) · Radiotherapy, Intensity-Modulated (1)
Klus Pharma Inc. (1) · Massachusetts General Hospital (1) · Poseida Therapeutics, Inc. (1)
United States (3)
Annie W Chan, MD (1) · Jordi Rodon Ahnert, MD, PhD (1) · Rajesh Belani, M.D. (1)
P01CA021239 (1)